CA2564120A1 - Procede servant a utiliser des lipides neutres afin de modifier la liberation in vivo depuis des liposomes a vesicules multiples - Google Patents

Procede servant a utiliser des lipides neutres afin de modifier la liberation in vivo depuis des liposomes a vesicules multiples Download PDF

Info

Publication number
CA2564120A1
CA2564120A1 CA002564120A CA2564120A CA2564120A1 CA 2564120 A1 CA2564120 A1 CA 2564120A1 CA 002564120 A CA002564120 A CA 002564120A CA 2564120 A CA2564120 A CA 2564120A CA 2564120 A1 CA2564120 A1 CA 2564120A1
Authority
CA
Canada
Prior art keywords
release rate
neutral lipid
component
lipid
active compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002564120A
Other languages
English (en)
Other versions
CA2564120C (fr
Inventor
Randall C. Willis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pacira Pharmaceuticals Inc
Original Assignee
Skyepharma Inc.
Randall C. Willis
Depotech Corporation
Pacira Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/792,566 external-priority patent/US5891467A/en
Application filed by Skyepharma Inc., Randall C. Willis, Depotech Corporation, Pacira Pharmaceuticals, Inc. filed Critical Skyepharma Inc.
Priority to CA2692302A priority Critical patent/CA2692302C/fr
Publication of CA2564120A1 publication Critical patent/CA2564120A1/fr
Application granted granted Critical
Publication of CA2564120C publication Critical patent/CA2564120C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
CA2564120A 1997-01-31 1998-01-29 Procede servant a utiliser des lipides neutres afin de modifier la liberation in vivo depuis des liposomes a vesicules multiples Expired - Lifetime CA2564120C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA2692302A CA2692302C (fr) 1997-01-31 1998-01-29 Procede servant a utiliser des lipides neutres afin de modifier la libe ation in vivo depuis des liposomes a vesicules multiples

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/792,566 1997-01-31
US08/792,566 US5891467A (en) 1997-01-31 1997-01-31 Method for utilizing neutral lipids to modify in vivo release from multivesicular liposomes
CA002277956A CA2277956C (fr) 1997-01-31 1998-01-29 Procede servant a utiliser des lipides neutres afin de modifier la liberation in vivo depuis des liposomes a vesicules multiples

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002277956A Division CA2277956C (fr) 1997-01-31 1998-01-29 Procede servant a utiliser des lipides neutres afin de modifier la liberation in vivo depuis des liposomes a vesicules multiples

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CA2692302A Division CA2692302C (fr) 1997-01-31 1998-01-29 Procede servant a utiliser des lipides neutres afin de modifier la libe ation in vivo depuis des liposomes a vesicules multiples

Publications (2)

Publication Number Publication Date
CA2564120A1 true CA2564120A1 (fr) 1998-08-06
CA2564120C CA2564120C (fr) 2010-04-13

Family

ID=37480474

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2564120A Expired - Lifetime CA2564120C (fr) 1997-01-31 1998-01-29 Procede servant a utiliser des lipides neutres afin de modifier la liberation in vivo depuis des liposomes a vesicules multiples

Country Status (1)

Country Link
CA (1) CA2564120C (fr)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1189597A1 (fr) * 1999-06-04 2002-03-27 SkyePharma Inc. Compositions a noyau huileux destinees a la liberation prolongee de medicaments hydrophobes
WO2013064837A1 (fr) * 2011-11-03 2013-05-10 Isis Innovation Limited Multisomes: réseaux de gouttelettes encapsulées
EP2813220A3 (fr) * 2010-04-09 2015-06-17 Pacira Pharmaceuticals, Inc. Procédé de formulation de vésicules membranaires synthétiques de grand diamètre
US9831010B2 (en) 2012-10-25 2017-11-28 Oxford University Innovation Limited Hydrogel network
US10950376B2 (en) 2012-10-25 2021-03-16 Oxford University Innovation Limited Droplet assembly method
US11213797B2 (en) 2012-12-07 2022-01-04 Oxford University Innovation Limited Droplet assembly by 3D printing
US11998642B2 (en) 2011-11-03 2024-06-04 Oxford University Innovation Limited Multisomes: encapsulated droplet networks

Cited By (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003501376A (ja) * 1999-06-04 2003-01-14 スカイファーマ インコーポレーテッド 疎水性薬物の持続性放出のための油コア組成物
EP1189597A4 (fr) * 1999-06-04 2008-06-18 Pacira Pharmaceuticals Inc Compositions a noyau huileux destinees a la liberation prolongee de medicaments hydrophobes
EP1189597A1 (fr) * 1999-06-04 2002-03-27 SkyePharma Inc. Compositions a noyau huileux destinees a la liberation prolongee de medicaments hydrophobes
US10045941B2 (en) 2010-04-09 2018-08-14 Pacira Pharmaceuticals, Inc. Method for formulating large diameter synthetic membrane vesicles
US10398648B2 (en) 2010-04-09 2019-09-03 Pacira Pharmaceuticals, Inc. Method for formulating large diameter synthetic membrane vesicles
EP2813220A3 (fr) * 2010-04-09 2015-06-17 Pacira Pharmaceuticals, Inc. Procédé de formulation de vésicules membranaires synthétiques de grand diamètre
US9724302B2 (en) 2010-04-09 2017-08-08 Pacira Pharmaceuticals, Inc. Method for formulating large diameter synthetic membrane vesicles
US9730892B2 (en) 2010-04-09 2017-08-15 Pacira Pharmaceuticals, Inc. Method for formulating large diameter synthetic membrane vesicles
US9737482B2 (en) 2010-04-09 2017-08-22 Pacira Pharmaceuticals, Inc. Method for formulating large diameter synthetic membrane vesicles
US9737483B2 (en) 2010-04-09 2017-08-22 Pacira Pharmaceuticals, Inc. Method for formulating large diameter synthetic membrane vesicles
US9757336B2 (en) 2010-04-09 2017-09-12 Pacira Pharmaceuticals, Inc. Method for formulating large diameter synthetic membrane vesicles
US9808424B2 (en) 2010-04-09 2017-11-07 Pacira Pharmaceuticals, Inc. Method for formulating large diameter synthetic membrane vesicles
AU2012330894B2 (en) * 2011-11-03 2017-07-13 Oxford University Innovation Limited Multisomes: encapsulated droplet networks
WO2013064837A1 (fr) * 2011-11-03 2013-05-10 Isis Innovation Limited Multisomes: réseaux de gouttelettes encapsulées
US10548852B2 (en) 2011-11-03 2020-02-04 Oxford University Innovation Limited Multisomes: encapsulated droplet networks
US11406603B2 (en) 2011-11-03 2022-08-09 Oxford University Innovation Limited Multisomes: encapsulated droplet networks
US11998642B2 (en) 2011-11-03 2024-06-04 Oxford University Innovation Limited Multisomes: encapsulated droplet networks
US9831010B2 (en) 2012-10-25 2017-11-28 Oxford University Innovation Limited Hydrogel network
US10950376B2 (en) 2012-10-25 2021-03-16 Oxford University Innovation Limited Droplet assembly method
US10978218B2 (en) 2012-10-25 2021-04-13 Oxford University Innovation Limited Hydrogel network
US11213797B2 (en) 2012-12-07 2022-01-04 Oxford University Innovation Limited Droplet assembly by 3D printing

Also Published As

Publication number Publication date
CA2564120C (fr) 2010-04-13

Similar Documents

Publication Publication Date Title
ES2529167T3 (es) Método para utilizar lípidos neutros para modificar la liberación in vivo desde liposomas multivesiculares
US5552155A (en) Fusogenic lipsomes and methods for making and using same
Mantripragada A lipid based depot (DepoFoam® technology) for sustained release drug delivery
CA2378438C (fr) Preparation d'agents therapeutiques a encapsulation lipidique
US5316771A (en) Method of amphiphatic drug loading in liposomes by ammonium ion gradient
Vora et al. Proniosome based transdermal delivery of levonorgestrel for effective contraception
CA1261751A (fr) Liposomes fusionnes et methode d'induction a l'acide pour la fusion de liposomes
FI92647C (fi) Menetelmä mikrokapseleiden valmistamiseksi
US4877561A (en) Method of producing liposome
EP1005326B1 (fr) Procede de production de liposomes comportant un pourcentage accru de compose encapsule
US20110177130A1 (en) Methods for preparation of lipid-encapsulated therapeutic agents
CA2376202A1 (fr) Preparation et forme galenique comprenant un compose actif acido-labile
US20010006643A1 (en) Method of loading preformed liposomes using ethanol
CA2245466A1 (fr) Composition d'ester de stanol et production de celle-ci
WO1998019709A3 (fr) Reactifs cationiques pour transfection
CA2106405A1 (fr) Vesicules lipidiques porteuses de gaz et d'oxygene
WO1992002244A1 (fr) Accumulation d'acides amines et de peptides dans des liposomes
CA2187748C (fr) Liposomes de fusion, leurs procedes de preparation et d'utilisation
CA2564120A1 (fr) Procede servant a utiliser des lipides neutres afin de modifier la liberation in vivo depuis des liposomes a vesicules multiples
AU6374596A (en) Biologically active composition comprising cyclosporine
CA2305533A1 (fr) Vesicules de coalescence multilamellaires (mlcv) contenant des composes biologiquement actifs
AU698915B2 (en) Ketoprofen liposomes
AU8298682A (en) Slow absorption salicylic acid preparation
ES2086802T3 (es) Formulaciones liposomicas de principios activos y procedimiento para su preparacion.
CA2346016C (fr) Liposome paucilamellaire a glucosides

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20180129